Wednesday, October 04, 2017 11:38:12 AM
TEAR 1.43 re-enter, as mentioned (May 2017 DD, link back) all point of revenues boost thru Q4 and beyond (time in now), strong cash on hand (about $1.75/share), 4 strong new markers, several Catalysts. source filings/September 2017 presentation:
• FDA filing for next generation platform (NGP)
• Summary of FDA clinical data
• Professional guidelines
• EU launch of NGP
• FDA approval of NGP
• U.S. launch of NGP
Revenues Model
First Generation Technical Achievments
First Generation Commercial Results
Current Numbers:
TEAR generating $28M revenue a/o August 2017 vs $7.7m Market cap (fully diluted about twice, still very low cap)
Market Value1
$7,752,312
a/o Oct 03, 2017
Outstanding Shares
5,742,453
a/o Aug 07, 2017
about 20% Ownership a/o today.
Edison predicted in 2015 a $145m sales on only a modest penetration. Company achieved it past months.
posted MRNS full DD a couple months ago at 1.24 (7.8 a/o today). same upside potential here for the mid-term (a couple months ahead).
• FDA filing for next generation platform (NGP)
• Summary of FDA clinical data
• Professional guidelines
• EU launch of NGP
• FDA approval of NGP
• U.S. launch of NGP
Revenues Model
First Generation Technical Achievments
First Generation Commercial Results
Current Numbers:
TEAR generating $28M revenue a/o August 2017 vs $7.7m Market cap (fully diluted about twice, still very low cap)
Market Value1
$7,752,312
a/o Oct 03, 2017
Outstanding Shares
5,742,453
a/o Aug 07, 2017
about 20% Ownership a/o today.
Edison predicted in 2015 a $145m sales on only a modest penetration. Company achieved it past months.
posted MRNS full DD a couple months ago at 1.24 (7.8 a/o today). same upside potential here for the mid-term (a couple months ahead).
My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
